Clinical trial
Development of a Novel Therapeutic for Smoking Cessation
NCT02217527 is registered in ClinicalTrials.gov with Chengappa, K.N. Roy, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Novel Therapeutic for Smoking Cessation
- Lead sponsor
- Chengappa, K.N. Roy, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- January 31, 2018
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation